LAIV Mutations Selectively Alter Influenza Viral RNA Polymerase Function, Favoring Transcription over Genome Synthesis

Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Viruses Jg. 17; H. 11; S. 1412
Hauptverfasser: Leach, Justin R., Oo, Adrian, Nogales, Aitor, Bosch, Sebastian I., Martínez-Sobrido, Luis, Feng, Changyong, Kim, Baek, Dewhurst, Stephen
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland MDPI AG 23.10.2025
Schlagworte:
ISSN:1999-4915, 1999-4915
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and cold-adapted mutations that render them safe. These mutations are principally located in the PB1 and PB2 subunits of the viral RNA polymerase, but the mechanism by which they attenuate the virus is unclear. We introduced the PB1 and PB2 mutations from two LAIV backbones, A/Ann Arbor/6/1960 H2N2 (AA) and A/Leningrad/134/17/1957 H2N2 (Len), into the model influenza strain A/Puerto Rico/8/1934 H1N1 (PR8). In contrast to the wild-type (WT) PR8 polymerase, the two “PR8-LAIV” polymerase complexes demonstrated maximal activity at cold temperatures (30–32 °C) and greatly reduced activity at elevated temperatures (>37 °C). To further understand the impact of the LAIV mutations, we infected MDCK cells with WT and mutated PR8 viruses that contain the Len and AA LAIV mutations in PB1 and PB2. The PR8-LAIV mutant viruses exhibited a selective, temperature-dependent defect in the replicase activity of the viral RNA polymerase relative to WT PR8, while also demonstrating a temperature-dependent enhancement in the transcriptional activity of the enzyme. In addition, the PR8-LAIV mutant viruses produced similar levels of viral proteins to WT PR8 at 37 °C, but greatly (2–3 log10) reduced levels of infectious viral progeny. Collectively, these data show that LAIV mutations selectively alter influenza viral RNA polymerase function, favoring transcription over genome synthesis at 37 °C, thereby preserving viral antigen production while also contributing to viral attenuation.
AbstractList Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and cold-adapted mutations that render them safe. These mutations are principally located in the PB1 and PB2 subunits of the viral RNA polymerase, but the mechanism by which they attenuate the virus is unclear. We introduced the PB1 and PB2 mutations from two LAIV backbones, A/Ann Arbor/6/1960 H2N2 (AA) and A/Leningrad/134/17/1957 H2N2 (Len), into the model influenza strain A/Puerto Rico/8/1934 H1N1 (PR8). In contrast to the wild-type (WT) PR8 polymerase, the two "PR8-LAIV" polymerase complexes demonstrated maximal activity at cold temperatures (30-32 °C) and greatly reduced activity at elevated temperatures (>37 °C). To further understand the impact of the LAIV mutations, we infected MDCK cells with WT and mutated PR8 viruses that contain the Len and AA LAIV mutations in PB1 and PB2. The PR8-LAIV mutant viruses exhibited a selective, temperature-dependent defect in the replicase activity of the viral RNA polymerase relative to WT PR8, while also demonstrating a temperature-dependent enhancement in the transcriptional activity of the enzyme. In addition, the PR8-LAIV mutant viruses produced similar levels of viral proteins to WT PR8 at 37 °C, but greatly (2-3 log ) reduced levels of infectious viral progeny. Collectively, these data show that LAIV mutations selectively alter influenza viral RNA polymerase function, favoring transcription over genome synthesis at 37 °C, thereby preserving viral antigen production while also contributing to viral attenuation.
Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and cold-adapted mutations that render them safe. These mutations are principally located in the PB1 and PB2 subunits of the viral RNA polymerase, but the mechanism by which they attenuate the virus is unclear. We introduced the PB1 and PB2 mutations from two LAIV backbones, A/Ann Arbor/6/1960 H2N2 (AA) and A/Leningrad/134/17/1957 H2N2 (Len), into the model influenza strain A/Puerto Rico/8/1934 H1N1 (PR8). In contrast to the wild-type (WT) PR8 polymerase, the two "PR8-LAIV" polymerase complexes demonstrated maximal activity at cold temperatures (30-32 °C) and greatly reduced activity at elevated temperatures (>37 °C). To further understand the impact of the LAIV mutations, we infected MDCK cells with WT and mutated PR8 viruses that contain the Len and AA LAIV mutations in PB1 and PB2. The PR8-LAIV mutant viruses exhibited a selective, temperature-dependent defect in the replicase activity of the viral RNA polymerase relative to WT PR8, while also demonstrating a temperature-dependent enhancement in the transcriptional activity of the enzyme. In addition, the PR8-LAIV mutant viruses produced similar levels of viral proteins to WT PR8 at 37 °C, but greatly (2-3 log10) reduced levels of infectious viral progeny. Collectively, these data show that LAIV mutations selectively alter influenza viral RNA polymerase function, favoring transcription over genome synthesis at 37 °C, thereby preserving viral antigen production while also contributing to viral attenuation.Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and cold-adapted mutations that render them safe. These mutations are principally located in the PB1 and PB2 subunits of the viral RNA polymerase, but the mechanism by which they attenuate the virus is unclear. We introduced the PB1 and PB2 mutations from two LAIV backbones, A/Ann Arbor/6/1960 H2N2 (AA) and A/Leningrad/134/17/1957 H2N2 (Len), into the model influenza strain A/Puerto Rico/8/1934 H1N1 (PR8). In contrast to the wild-type (WT) PR8 polymerase, the two "PR8-LAIV" polymerase complexes demonstrated maximal activity at cold temperatures (30-32 °C) and greatly reduced activity at elevated temperatures (>37 °C). To further understand the impact of the LAIV mutations, we infected MDCK cells with WT and mutated PR8 viruses that contain the Len and AA LAIV mutations in PB1 and PB2. The PR8-LAIV mutant viruses exhibited a selective, temperature-dependent defect in the replicase activity of the viral RNA polymerase relative to WT PR8, while also demonstrating a temperature-dependent enhancement in the transcriptional activity of the enzyme. In addition, the PR8-LAIV mutant viruses produced similar levels of viral proteins to WT PR8 at 37 °C, but greatly (2-3 log10) reduced levels of infectious viral progeny. Collectively, these data show that LAIV mutations selectively alter influenza viral RNA polymerase function, favoring transcription over genome synthesis at 37 °C, thereby preserving viral antigen production while also contributing to viral attenuation.
Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and cold-adapted mutations that render them safe. These mutations are principally located in the PB1 and PB2 subunits of the viral RNA polymerase, but the mechanism by which they attenuate the virus is unclear. We introduced the PB1 and PB2 mutations from two LAIV backbones, A/Ann Arbor/6/1960 H2N2 (AA) and A/Leningrad/134/17/1957 H2N2 (Len), into the model influenza strain A/Puerto Rico/8/1934 H1N1 (PR8). In contrast to the wild-type (WT) PR8 polymerase, the two “PR8-LAIV” polymerase complexes demonstrated maximal activity at cold temperatures (30–32 °C) and greatly reduced activity at elevated temperatures (>37 °C). To further understand the impact of the LAIV mutations, we infected MDCK cells with WT and mutated PR8 viruses that contain the Len and AA LAIV mutations in PB1 and PB2. The PR8-LAIV mutant viruses exhibited a selective, temperature-dependent defect in the replicase activity of the viral RNA polymerase relative to WT PR8, while also demonstrating a temperature-dependent enhancement in the transcriptional activity of the enzyme. In addition, the PR8-LAIV mutant viruses produced similar levels of viral proteins to WT PR8 at 37 °C, but greatly (2–3 log10) reduced levels of infectious viral progeny. Collectively, these data show that LAIV mutations selectively alter influenza viral RNA polymerase function, favoring transcription over genome synthesis at 37 °C, thereby preserving viral antigen production while also contributing to viral attenuation.
Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary prophylactic strategy. Live attenuated influenza vaccines (LAIVs) efficiently induce antiviral immune responses and contain temperature-sensitive and cold-adapted mutations that render them safe. These mutations are principally located in the PB1 and PB2 subunits of the viral RNA polymerase, but the mechanism by which they attenuate the virus is unclear. We introduced the PB1 and PB2 mutations from two LAIV backbones, A/Ann Arbor/6/1960 H2N2 (AA) and A/Leningrad/134/17/1957 H2N2 (Len), into the model influenza strain A/Puerto Rico/8/1934 H1N1 (PR8). In contrast to the wild-type (WT) PR8 polymerase, the two “PR8-LAIV” polymerase complexes demonstrated maximal activity at cold temperatures (30–32 °C) and greatly reduced activity at elevated temperatures (>37 °C). To further understand the impact of the LAIV mutations, we infected MDCK cells with WT and mutated PR8 viruses that contain the Len and AA LAIV mutations in PB1 and PB2. The PR8-LAIV mutant viruses exhibited a selective, temperature-dependent defect in the replicase activity of the viral RNA polymerase relative to WT PR8, while also demonstrating a temperature-dependent enhancement in the transcriptional activity of the enzyme. In addition, the PR8-LAIV mutant viruses produced similar levels of viral proteins to WT PR8 at 37 °C, but greatly (2–3 log[sub.10]) reduced levels of infectious viral progeny. Collectively, these data show that LAIV mutations selectively alter influenza viral RNA polymerase function, favoring transcription over genome synthesis at 37 °C, thereby preserving viral antigen production while also contributing to viral attenuation.
Audience Academic
Author Feng, Changyong
Nogales, Aitor
Bosch, Sebastian I.
Oo, Adrian
Dewhurst, Stephen
Leach, Justin R.
Martínez-Sobrido, Luis
Kim, Baek
Author_xml – sequence: 1
  givenname: Justin R.
  orcidid: 0000-0001-8716-4785
  surname: Leach
  fullname: Leach, Justin R.
– sequence: 2
  givenname: Adrian
  orcidid: 0000-0002-2469-5391
  surname: Oo
  fullname: Oo, Adrian
– sequence: 3
  givenname: Aitor
  orcidid: 0000-0002-2424-7900
  surname: Nogales
  fullname: Nogales, Aitor
– sequence: 4
  givenname: Sebastian I.
  orcidid: 0000-0002-7947-8853
  surname: Bosch
  fullname: Bosch, Sebastian I.
– sequence: 5
  givenname: Luis
  orcidid: 0000-0001-7084-0804
  surname: Martínez-Sobrido
  fullname: Martínez-Sobrido, Luis
– sequence: 6
  givenname: Changyong
  orcidid: 0000-0002-4432-1565
  surname: Feng
  fullname: Feng, Changyong
– sequence: 7
  givenname: Baek
  surname: Kim
  fullname: Kim, Baek
– sequence: 8
  givenname: Stephen
  surname: Dewhurst
  fullname: Dewhurst, Stephen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41305435$$D View this record in MEDLINE/PubMed
BookMark eNpdktuO0zAQhiO0iD3ABS-ALHEDEl18iOPkslrRpVI5iF32Npo44-IqsYudRCpPj0OXCiFf2Pr1zT8znrnMzpx3mGUvGb0WoqLvJ6YYYznjT7ILVlXVIq-YPPvnfZ5dxrijtCgqqp5l5zkTVOZCXmTTZrl-IJ_GAQbrXSR32KEe7ITdgSy7AQNZO9ON6H4BebABOvLt85J89d2hxwARyWp0eg59R1Yw-WDdltwHcFEHu5914qdkcovO90juDm74gdHG59lTA13EF4_3VfZ99eH-5uNi8-V2fbPcLDSXJV8YoxRyaDloDqURQrWiKFgFUmrOkMqmBakomFLISgHPm7ahtNElomDKFOIqWx99Ww-7eh9sD-FQe7D1H8GHbQ1hsLrD2gijJZqW51WeY0oihGFgKsWU0nnbJK83R6998D9HjEPd26ix68ChH2MtuCoYLdOnJ_T1f-jOj8GlTmdKppJ5NRd3faS2kPJbZ_wQQKfTYm91GrGxSV-WhVRlkZdzwKtH27HpsT3183ecCXh7BHTwMQY0J4TRel6V-rQq4jdwLq8b
Cites_doi 10.1038/nprot.2014.180
10.1007/978-1-4939-8678-1
10.1128/jvi.00337-23
10.1016/S1473-3099(17)30360-2
10.1074/jbc.M111.262048
10.1038/s44319-024-00208-4
10.1016/j.vaccine.2015.07.023
10.1128/JVI.02636-14
10.1016/j.ijid.2014.05.016
10.1038/s41467-024-48470-3
10.3390/v11100928
10.1128/CVI.00414-16
10.1016/j.coviro.2016.01.016
10.1016/j.vaccine.2017.09.058
10.3390/v10100560
10.1016/j.vaccine.2013.12.069
10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
10.1099/vir.0.020370-0
10.3390/vaccines3020373
10.1093/infdis/jit207
10.3389/fimmu.2016.00195
10.1128/JVI.01025-18
10.1016/j.jviromet.2010.12.014
10.1038/213612a0
10.1038/s41586-019-1530-7
10.1128/JVI.01477-12
10.1038/s41467-024-51007-3
ContentType Journal Article
Copyright COPYRIGHT 2025 MDPI AG
2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2025 MDPI AG
– notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.3390/v17111412
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1999-4915
ExternalDocumentID oai_doaj_org_article_f3fc5efd24944e61933f1af97177c4db
A865786486
41305435
10_3390_v17111412
Genre Journal Article
GeographicLocations California
United States
Massachusetts
Michigan
Russia
Ann Arbor Michigan
United States--US
Puerto Rico
GeographicLocations_xml – name: Michigan
– name: Russia
– name: California
– name: United States
– name: Massachusetts
– name: Ann Arbor Michigan
– name: Puerto Rico
– name: United States--US
GrantInformation_xml – fundername: NIH HHS
  grantid: GM135134
GroupedDBID ---
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACUHS
AFFHD
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E3Z
EBD
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M7P
MODMG
M~E
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
RPM
TR2
TUS
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7U9
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
M48
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c2582-ff77e2ad2ac2a8f337d36619a55c21e05bda570af83597a24bdb00bc8ee317f63
IEDL.DBID DOA
ISSN 1999-4915
IngestDate Mon Dec 01 19:28:37 EST 2025
Thu Nov 27 17:32:28 EST 2025
Thu Nov 27 00:40:51 EST 2025
Tue Dec 02 03:50:52 EST 2025
Mon Dec 01 01:41:29 EST 2025
Sat Nov 29 06:59:21 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords influenza
LAIV
H1N1
polymerase
vaccination
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2582-ff77e2ad2ac2a8f337d36619a55c21e05bda570af83597a24bdb00bc8ee317f63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4432-1565
0000-0002-2469-5391
0000-0002-7947-8853
0000-0001-7084-0804
0000-0002-2424-7900
0000-0001-8716-4785
OpenAccessLink https://doaj.org/article/f3fc5efd24944e61933f1af97177c4db
PMID 41305435
PQID 3275570296
PQPubID 2032319
ParticipantIDs doaj_primary_oai_doaj_org_article_f3fc5efd24944e61933f1af97177c4db
proquest_miscellaneous_3276108199
proquest_journals_3275570296
gale_infotracacademiconefile_A865786486
pubmed_primary_41305435
crossref_primary_10_3390_v17111412
PublicationCentury 2000
PublicationDate 2025-Oct-23
PublicationDateYYYYMMDD 2025-10-23
PublicationDate_xml – month: 10
  year: 2025
  text: 2025-Oct-23
  day: 23
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Viruses
PublicationTitleAlternate Viruses
PublicationYear 2025
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References Kawakami (ref_18) 2011; 173
ref_14
ref_13
Maassab (ref_20) 1999; 9
Grant (ref_3) 2016; 16
ref_10
Maassab (ref_11) 1967; 213
Staller (ref_25) 2024; 15
Zens (ref_4) 2019; 1
Seitz (ref_29) 2010; 91
Fischer (ref_21) 2014; 32
Li (ref_23) 2014; 27
Cox (ref_15) 2015; 89
ref_19
Zhang (ref_22) 2023; 97
Hoft (ref_7) 2017; 24
Aggarwal (ref_16) 2011; 286
Eisfeld (ref_1) 2014; 9
Forero (ref_24) 2017; 35
Sun (ref_27) 2024; 25
Fan (ref_26) 2019; 573
Singanayagam (ref_2) 2018; 18
Wan (ref_5) 2018; 92
Fischer (ref_30) 2015; 33
Cox (ref_12) 1988; 167
(ref_17) 2010; 42
Sridhar (ref_9) 2015; 3
Arragain (ref_28) 2024; 15
Cheng (ref_6) 2013; 208
Ilyushina (ref_8) 2012; 86
References_xml – volume: 9
  start-page: 2663
  year: 2014
  ident: ref_1
  article-title: Influenza A virus isolation, culture and identification
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2014.180
– ident: ref_19
  doi: 10.1007/978-1-4939-8678-1
– volume: 97
  start-page: e0033723
  year: 2023
  ident: ref_22
  article-title: Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins
  publication-title: J. Virol.
  doi: 10.1128/jvi.00337-23
– volume: 18
  start-page: e25
  year: 2018
  ident: ref_2
  article-title: Urgent challenges in implementing live attenuated influenza vaccine
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(17)30360-2
– volume: 286
  start-page: 34504
  year: 2011
  ident: ref_16
  article-title: Biochemical Impact of the Host Adaptation-associated PB2 E627K Mutation on the Temperature-dependent RNA Synthesis Kinetics of Influenza A Virus Polymerase Complex
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.262048
– volume: 25
  start-page: 4708
  year: 2024
  ident: ref_27
  article-title: NS2 induces an influenza A RNA polymerase hexamer and acts as a transcription to replication switch
  publication-title: EMBO Rep.
  doi: 10.1038/s44319-024-00208-4
– volume: 33
  start-page: 4495
  year: 2015
  ident: ref_30
  article-title: Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.07.023
– volume: 42
  start-page: 2057
  year: 2010
  ident: ref_17
  article-title: Generation of recombinant influenza virus from plasmid DNA
  publication-title: J. Vis. Exp.
– volume: 89
  start-page: 3421
  year: 2015
  ident: ref_15
  article-title: Development of a Mouse-Adapted Live Attenuated Influenza Virus That Permits In Vivo Analysis of Enhancements to the Safety of Live Attenuated Influenza Virus Vaccine
  publication-title: J. Virol.
  doi: 10.1128/JVI.02636-14
– volume: 27
  start-page: 37
  year: 2014
  ident: ref_23
  article-title: T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2014.05.016
– volume: 15
  start-page: 4123
  year: 2024
  ident: ref_25
  article-title: Structures of H5N1 influenza polymerase with ANP32B reveal mechanisms of genome replication and host adaptation
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-024-48470-3
– ident: ref_13
  doi: 10.3390/v11100928
– volume: 24
  start-page: e00414
  year: 2017
  ident: ref_7
  article-title: Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults
  publication-title: Clin. Vaccine Immunol.
  doi: 10.1128/CVI.00414-16
– volume: 16
  start-page: 132
  year: 2016
  ident: ref_3
  article-title: Human influenza viruses and CD8+ T cell responses
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2016.01.016
– volume: 35
  start-page: 6112
  year: 2017
  ident: ref_24
  article-title: Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2017.09.058
– ident: ref_14
  doi: 10.3390/v10100560
– volume: 32
  start-page: 1761
  year: 2014
  ident: ref_21
  article-title: Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2013.12.069
– volume: 9
  start-page: 237
  year: 1999
  ident: ref_20
  article-title: The development of live attenuated cold-adapted influenza virus vaccine for humans
  publication-title: Rev. Med. Virol.
  doi: 10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
– volume: 91
  start-page: 1754
  year: 2010
  ident: ref_29
  article-title: High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.020370-0
– volume: 3
  start-page: 373
  year: 2015
  ident: ref_9
  article-title: Influenza vaccination strategies: Comparing inactivated and live attenuated influenza vaccines
  publication-title: Vaccines
  doi: 10.3390/vaccines3020373
– volume: 208
  start-page: 594
  year: 2013
  ident: ref_6
  article-title: Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jit207
– ident: ref_10
  doi: 10.3389/fimmu.2016.00195
– volume: 92
  start-page: e01025-18
  year: 2018
  ident: ref_5
  article-title: Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine
  publication-title: J. Virol.
  doi: 10.1128/JVI.01025-18
– volume: 173
  start-page: 1
  year: 2011
  ident: ref_18
  article-title: Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2010.12.014
– volume: 213
  start-page: 612
  year: 1967
  ident: ref_11
  article-title: Adaptation and growth characteristics of influenza virus at 25 °C
  publication-title: Nature
  doi: 10.1038/213612a0
– volume: 1
  start-page: e85832
  year: 2019
  ident: ref_4
  article-title: Vaccine-generated lung tissue–resident memory T cells provide heterosubtypic protection to influenza infection
  publication-title: JCI Insight
– volume: 573
  start-page: 287
  year: 2019
  ident: ref_26
  article-title: Structures of influenza A virus RNA polymerase offer insight into viral genome replication
  publication-title: Nature
  doi: 10.1038/s41586-019-1530-7
– volume: 167
  start-page: 554
  year: 1988
  ident: ref_12
  article-title: Identification of Sequence Changes in the Cold-Adapted, Live Attenuated Influenza Vaccine Strain, A/Ann Arbor/6/60 (H2N2)
  publication-title: Virology
– volume: 86
  start-page: 11725
  year: 2012
  ident: ref_8
  article-title: Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway Epithelium
  publication-title: J. Virol.
  doi: 10.1128/JVI.01477-12
– volume: 15
  start-page: 6910
  year: 2024
  ident: ref_28
  article-title: Structures of influenza A and B replication complexes give insight into avian to human host adaptation and reveal a role of ANP32 as an electrostatic chaperone for the apo-polymerase
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-024-51007-3
SSID ssj0066907
Score 2.3997993
Snippet Influenza viruses cause mild to severe lower respiratory infections, sometimes resulting in hospitalization and death. Vaccination remains the primary...
SourceID doaj
proquest
gale
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
StartPage 1412
SubjectTerms Analysis
Animals
Cell Line
DNA-directed RNA polymerase
DNA-Directed RNA Polymerases - genetics
DNA-Directed RNA Polymerases - metabolism
Dogs
Enzymes
Ethylenediaminetetraacetic acid
Genes
Genetic aspects
Genetic transcription
Genome, Viral
Genomics
H1N1
Health aspects
High temperature
Humans
Immune response
Influenza
Influenza A Virus, H1N1 Subtype - enzymology
Influenza A Virus, H1N1 Subtype - genetics
Influenza A Virus, H1N1 Subtype - immunology
Influenza A Virus, H2N2 Subtype - enzymology
Influenza A Virus, H2N2 Subtype - genetics
Influenza vaccines
Influenza Vaccines - genetics
Influenza Vaccines - immunology
Influenza viruses
LAIV
Madin Darby Canine Kidney Cells
Mutants
Mutation
Penicillin
polymerase
Proteins
Replicase
Respiratory tract infection
RNA
RNA polymerase
RNA-Dependent RNA Polymerase - genetics
RNA-Dependent RNA Polymerase - metabolism
Temperature
Transcription
Transcription, Genetic
Vaccination
Vaccines
Vaccines, Attenuated - genetics
Vaccines, Attenuated - immunology
Viral antigens
Viral infections
Viral proteins
Viral Proteins - genetics
Viral Proteins - metabolism
Virus Replication
Viruses
SummonAdditionalLinks – databaseName: Biological Science Database (ProQuest)
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB-0Kvjid220llUEXwy97G6-niSKVwv1OKyWvoXNfpSDNqnJ3cH51zuzSU5U8MXHJJtlwnz9ZmcyA_C6ymUVydiEEyt0iPFGFCqOl9oi9k5klU2sn1pyks5m2fl5Ph8O3LqhrHK0id5Qm0bTGfmh4Cl1i-J58u76e0hToyi7OozQuAm3qEuC8KV789ESJxT59d2EBIb2h-soRc2WEf_NB_lW_X8b5D9gpnc30_v_S-gDuDcATVb0kvEQbtj6EdzpR09uHsP6pDg-Y59XfSa-Y6d-Hg6avssNKyiDzo778SU_FDtbtLjTl1nB5s3lhk6xOsum6BDp1bdsqta-io95vzdaIUa1oezI1s2VZaebGoFmt-iewLfpx68fPoXDDIZQ8xjBt3NparkyXGmuMidEagS69FzFseaRncSVUfi1yiGSy1PFZWVQkSudWYvIxCViF3bqprZ7wJIKYx1udYoIAr2gqSQyCCUoSRw1kDQBvBq5Ul73rTZKDFGIdeWWdQG8J35tF1B3bH-jaS_KQdlKJ5yOrTMYWkppkVohXKRcjqFrqqWpAnhD3C5Jh5et0mr4FQHppG5YZZElaMgSFNYA9kcml4Nyd-UvDgfwcvsY1ZJyLaq2zcqvQWCKcCsP4GkvSFuaCTfECFOf_Xvz53CX07BhdJRc7MPOsl3ZF3Bbr5eLrj3wkv4TEmIH6w
  priority: 102
  providerName: ProQuest
Title LAIV Mutations Selectively Alter Influenza Viral RNA Polymerase Function, Favoring Transcription over Genome Synthesis
URI https://www.ncbi.nlm.nih.gov/pubmed/41305435
https://www.proquest.com/docview/3275570296
https://www.proquest.com/docview/3276108199
https://doaj.org/article/f3fc5efd24944e61933f1af97177c4db
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1999-4915
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0066907
  issn: 1999-4915
  databaseCode: DOA
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1999-4915
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0066907
  issn: 1999-4915
  databaseCode: M~E
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database (ProQuest)
  customDbUrl:
  eissn: 1999-4915
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0066907
  issn: 1999-4915
  databaseCode: M7P
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1999-4915
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0066907
  issn: 1999-4915
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1999-4915
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0066907
  issn: 1999-4915
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1999-4915
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0066907
  issn: 1999-4915
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9swED62boO9lP3s3LVBG4O9zDSWbMt-dEuzBdpg2q1kT0aWJQh0zoiTQPbX705ywtY99GUvBluyke90931nyXcAH-o8rqM4acKhETrEeCMKFcdTbZB7p3GdDY2rWnIhJ5NsOs3LP0p90Z4wnx7YC-7ECqsTYxsME-LYIN0XwkbK5hiGSB03NXlfZD3bYMr74JRiPp9HSGBQf7KOJNp0HPG_0Mcl6f_XFd8hmA5oRs9gv2eIrPAjew4PTPsCnviakZuXsL4oxjfscuWX0Dt27QrZoM-63bCClr7Z2Ncd-aXYzWyBT7qaFKyc327o81Nn2AiRjG79xEZq7bbfMQdYW_fBaFMn-2za-Q_DrjctMsRu1r2Cb6Pzr2dfwr54Qqh5gqzZWikNVw1XmqvMCiEbgVicqyTRPDLDpG5UIofKIgXLpeJx3aAF1jozBimFTcVr2GvnrXkDLK0xSOFGS4R-hK-mjlG-qPo0tZT5sQng_Vao1U-fI6PC2IIkX-0kH8ApiXvXgdJauwuo7KpXdnWfsgP4SMqqyPiWC6VV_w8BjpPSWFVFlqIHSnGWBXC01WfVW2VXCS4p4xjPsfndrhntiRZJVGvmK9cHGSXypDyAAz8PdmMmwE-QXx7-j3d5C0851RJGHOTiCPaWi5U5hsd6vZx1iwE8lFPpjtkAHp2eT8qrgZviA9qdWuK1cnxZfv8N4M4Abg
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtNAFL0qBVQ2vCmGAgMCscFqPOPnAiHzCI2aRhEtVXfDeB4oUrGLnQSZj-IbuTOOgwCJXRcs_ch4kpw591z7-h6Ap0UWFkEYKX-gmfQx3wh8QXFTatTecVikA-1cS8bJZJKenGTTDfjRvwtjyyp7TnRErSpp75HvMprYblE0i1-dffWta5R9utpbaHSw2NftN0zZmpejt_j_PqN0-O7ozZ6_chXwJY1QThqTJJoKRYWkIjWMJYphkMpEFEka6EFUKIEXEga1SZYIGhYKoVnIVGuMtSZmOO4FuIgygqauVHDaM39sM82uexFj2WB3GSTIJGFAf4t5zhrg7wDwh6x14W147X_7Ya7D1ZWQJnmH_BuwocubcLmz1mxvwXKcj47JwaKrNGjIofP7QWo_bUluKwTIqLNn-S7I8azGkT5McjKtTlt7l67RZIgB3370BRmKpatSJC6u9yxLbO0rea_L6osmh22JQrqZNbfh47l86TuwWValvgskLjCXo1omqJAwyqsiREDgColjYxtkKg-e9CjgZ10rEY4pmIUKX0PFg9cWH-sTbPdvt6OqP_MVmXDDjIy0UZg6h6HG2TJmAmEyTM0TGarCg-cWXdxy1LwWUqxetcB52m5fPE9jJOoYF6MHOz2o-Iq8Gv4LUR48Xh9G2rHPkkSpq4U7B4U3ysnMg-0OuOs5W10UoQy_9-_BH8HW3tHBmI9Hk_37cIVaY2UUBZTtwOa8XugHcEku57OmfuhWGYFP543enxSJZVo
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9NAEB2VAhUXvguGAgsCccFKvOuP-ICQoRiihiiiUPVm1utdFKnYJU6CzE_j1zGztoMAiVsPHJM4m03y5s0bezwP4HEe-7nnB4U71EK5WG94ruT4UGnU3qGfj4baupZMoul0dHwcz7bgR38vDLVV9pxoibqoFJ0jHwge0bQoHocD07VFzPbTF6dfXXKQoiutvZ1GC5ED3XzD8q1-Pt7H__oJ5-nrD6_eup3DgKt4gNLSmCjSXBZcKi5HRoioEJiwYhkEint6GOSFxA-VBnVKHEnu5wXCNFcjrTHvmlDguufgfERDy23b4KzPAiFVne0kIyHi4WDtRcgqvsd_y3_WJuDvZPCHxLWpLr3yP_9IV-FyJ7BZ0kbENdjS5XW42FpuNjdgPUnGR-zdqu1AqNmh9QFCyj9pWEKdA2zc2rZ8l-xovsCV3k8TNqtOGjp7V2uWohCgtz5jqVzb7kVm833Pvox6YtkbXVZfNDtsShTY9by-CR_P5EvvwnZZlfo2sDDHGo9rFaFywuxf5D6CAyMnDA0NziwceNQjIjttR4xkWJoRbLINbBx4SVjZHEBTwe0T1eJz1pFMZoRRgTYFltS-r3G3QhhPmhhL9kj5Re7AU0JaRty1XEglu1swcJ80BSxLRiESeIhB6sBeD7CsI7U6-4UuBx5uXkY6omtMstTVyh6DsYAyM3bgVgvizZ5JLwUoz-_8e_EHsIOgzSbj6cFduMTJbxm1Ahd7sL1crPQ9uKDWy3m9uG8DjsGnswbvT9x1bhc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LAIV+Mutations+Selectively+Alter+Influenza+Viral+RNA+Polymerase+Function%2C+Favoring+Transcription+over+Genome+Synthesis&rft.jtitle=Viruses&rft.au=Leach%2C+Justin+R&rft.au=Oo%2C+Adrian&rft.au=Nogales%2C+Aitor&rft.au=Bosch%2C+Sebastian+I&rft.date=2025-10-23&rft.pub=MDPI+AG&rft.issn=1999-4915&rft.eissn=1999-4915&rft.volume=17&rft.issue=11&rft_id=info:doi/10.3390%2Fv17111412&rft.externalDocID=A865786486
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon